Amit Sachdev Vertex Pharmaceuticals Inc (VRTX) insider trading activity

Amit Sachdev is EVP Chief Patient & Ext Af Off of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 68,490 shares of VRTX, which is worth approximately $33.2 Million. The most recent transaction as insider was on Feb 17, 2022, when has been sold 3,497 shares (Common Stock) at a price of $232.51 per share, resulting in proceeds of $813,087. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 68.5K

23.8% 3M change

23.8% 12M change

Total Value Held $33.2 Million

Amit Sachdev Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 17 2022	SELL Payment of exercise price or tax liability	$813,087 $232.51 p/Share	3,497 Reduced 5.92%	55,578 Common Stock
Feb 10 2022	SELL Payment of exercise price or tax liability	$592,210 $237.74 p/Share	2,491 Reduced 4.05%	59,075 Common Stock
Feb 01 2022	BUY Grant, award, or other acquisition	-	29,638 Added 32.5%	61,566 Common Stock
Nov 15 2021	SELL Open market or private sale	$9,544 $187.13 p/Share	51 Reduced 0.16%	31,928 Common Stock
May 17 2021	SELL Open market or private sale	$9,739 $216.42 p/Share	45 Reduced 0.11%	40,133 Common Stock
Apr 27 2021	SELL Open market or private sale	$841,469 $216.65 p/Share	3,884 Reduced 8.82%	40,133 Common Stock
Apr 27 2021	BUY Exercise of conversion of derivative security	$336,044 $86.52 p/Share	3,884 Added 8.11%	44,017 Common Stock
Feb 25 2021	SELL Open market or private sale	$768,300 $214.25 p/Share	3,586 Reduced 8.2%	40,133 Common Stock
Feb 24 2021	SELL Payment of exercise price or tax liability	$640,961 $217.57 p/Share	2,946 Reduced 6.31%	43,719 Common Stock
Feb 18 2021	SELL Open market or private sale	$1,960,540 $211.63 p/Share	9,264 Reduced 16.56%	46,665 Common Stock
Feb 17 2021	SELL Payment of exercise price or tax liability	$1,612,053 $211.75 p/Share	7,613 Reduced 11.98%	55,929 Common Stock
Feb 11 2021	SELL Open market or private sale	$941,997 $211.21 p/Share	4,460 Reduced 6.56%	63,542 Common Stock
Feb 10 2021	SELL Payment of exercise price or tax liability	$518,481 $214.16 p/Share	2,421 Reduced 3.44%	68,002 Common Stock
Feb 03 2021	BUY Grant, award, or other acquisition	-	32,077 Added 31.29%	70,423 Common Stock
Nov 16 2020	SELL Open market or private sale	$9,390 $223.57 p/Share	42 Reduced 0.12%	35,103 Common Stock

Also insider at

EIGR

Eiger BioPharmaceuticals, Inc. Healthcare

Amit Sachdev

EVP Chief Patient & Ext Af Off

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRTX shares.

Notify only if

Value

Insider Trading

Get notified when an Vertex Pharmaceuticals Inc insider buys or sells VRTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to VERTEX PHARMACEUTICALS INC

Track Activities on VRTX

Account